SUCJECTS AND METHODS: Forty-three patients with CAD (mean age:58, 32 men), 18 age and sex matched healthy people (mean age:52, 9 men) and 16 patients (mean age:53, 12 men) with atherosclerosis risk factor only were enrolled. The endothelial function (flow-mediated brachial artery dilation, FMD) and CIMT were measured by high-resolution ultrasound and the arterial stiffness by an oscillometric method.

RESULTS: There was a significant difference between the CAD and risk factor groups (3.46±1.3% vs. 5.77±2.54%, p<0.05), but there was no significant difference between the risk factor and healthy groups (5.29±2.0% vs. 5.77±2.54%, p>0.05) in the measured FMD. The CIMT showed a significant difference between the CAD and healthy groups (0.89±0.14 mm vs. 0.78±0.07 mm, p<0.05), but there was no significant difference between the CAD and risk factor groups(0.89±0.14 mm vs. 0.83±0.12 mm, p>0.05). There were significant differences among all groups in relation to the arterial stiffness (CAD group:1524±289 cm/sec, risk group:1342±202 cm/sec, healthy group:1195±119 cm/sec, p<0.05). The arterial stiffness showed significant correlation with the FMD (r=-0.322, p=0.005) and CIMT (r=0.310, p=0.007).

CONCLUSION: Of the 3 surrogates, the arterial stiffness measurement showed the best reliability in differentiating the CAD from the risk factor only groups as well as from healthy subjects. This study suggests the arterial stiffness can be used as a novel noninvasive test for early diagnosis of CAD in patients at high risk of atherosclerosis.